Diversity in probiotics and diversity in clinical trials: Opportunities for improvement
- PMID: 34325752
- DOI: 10.1017/ice.2021.290
Diversity in probiotics and diversity in clinical trials: Opportunities for improvement
Comment on
-
A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization.Infect Control Hosp Epidemiol. 2022 Feb;43(2):167-173. doi: 10.1017/ice.2021.94. Epub 2021 Apr 6. Infect Control Hosp Epidemiol. 2022. PMID: 33820576 Clinical Trial.